You are here

Home > News > News

Top Stories

Antibody niche

How to Neutralize the Coronavirus: Learning from the Body

12.05.2020
Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs
Making copies of existing antibodies could be fast track to treatment
Dan Davidi and family

A Scientist in the Eye of the Storm

10.05.2020
People and Events
Dr. Dan Davidi, a Weizmann alumnus, has weathered the pandemic in Boston with his family
root

The Soil Talks Back

07.05.2020
Systems Biology, Viruses & Microorganisms, Environment, Climate
Learning to decipher this language might help grow better crops or increase production of plant-based drugs
Irit Sagi

The Israel Institute for Biological Research and the Weizmann Institute of Science Collaborate to Fight Coronavirus

06.05.2020
Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
A milestone in relations between the two institutes could advance a cure 
Nir London

Israeli-American-British Labs and Biotech Partner to Speed Coronavirus Drug Development

04.05.2020
Bioinformatics and Computational Biology, Immunology, Disease, Drugs & Diagnostics, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
An international initiative aims to identify compounds that target a key enzyme in the virus's life cycle
Unconscious Patient (Allegory of Smell), Rembrandt van Rijn. The painting is part of a series of Five Senses that Rembrandt painted in Leiden around 1625, when he was 19. It was discovered in 2015 in an art collection belonging to a family from New Jersey

Weizmann Institute Scientists Develop "Sniff Test" that Predicts Recovery of Consciousness in Brain-Injured Patients

29.04.2020
Brain & Behavior, Disease, Drugs & Diagnostics
The Ultimate Decoy and Antibodies in the Fight Against Coronavirus

The Ultimate Decoy and Antibodies in the Fight Against Coronavirus

26.04.2020
Structural Biology, Life Sciences, Viruses & Microorganisms, Disease, Drugs & Diagnostics
Dr. Ron Diskin of the Weizmann Institute's Structural Biology Department is concentrating his efforts on a two-pronged research project against the current coronavirus
The Self-Synthesizing Ribosome

The Self-Synthesizing Ribosome

20.04.2020
Chemistry, Nanoscience, Biochemistry, Genetics, Technology & Applications
This cellular factory-on-a-chip could be used to design, produce and test drugs against antibiotic resistant bacteria
Prof. Sarel Fleishman. His research has already led to the design of a potential malaria vaccine, and he is now concentrating his efforts on the coronavirus

Slipping through the Coronavirus's Defense

19.04.2020
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs
Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process
Prof. Robert Fluhr, director of the Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute of Science, receives the first shipment of tests arriving at the Weizmann Institute

The Weizmann Institute of Science Began to Conduct Coronavirus Testing Today

10.04.2020
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Benefiting Humanity
The tests will be carried out at the Nancy and Stephen Grand Israel National Center for Personalized Medicine

Pages

   

Press Releases
See All >
07.01.2021
A Brain Mechanism underlying “Vision” in the Blind is Revealed
The research setup included an intake at the top of the mast. The Tara research schooner, 2016
23.12.2020
Plastic is Blowing in the Wind
16.12.2020
How Cancers Hurt Themselves to Hurt Immune Cells More